InsidersTradesSigma
Follow the 众生药业 share price and the full directors' dealings record of the company, a listed issuer based in China. Shares are listed on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 众生药业 has recorded 3 insider filings. Market capitalisation: €22.3bn. The latest transaction was reported on 26 April 2024 (Purchase). Among the most active insiders: 陈永红. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
众生药业 is a company operating in the health and pharmaceutical sector, listed on the XSHE market. It focuses on the research, development, and production of innovative medications.